Your search history is turned on.
Date: June 28, 2013 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
News Release TSX Symbol: MYG MIRATI THERAPEUTICS AND METHYLGENE ANNOUNCE COMPLETION OF PLAN OF ARRANGEMENT Mirati Therapeutics Begins Operations San Diego, California and Montreal, Canada, June 28, 2013 MethylGene Inc. (MethylGene) (TSX:MYG) and Mirati Therapeutics Inc. (Mirati Therapeutics) today announced the...
Microsoft Word - #6114941-v1-Notice of Change in Corp Structure.DOC 6114941 v1 Notice of Change in Corporate Structure Pursuant to Section 4.9 of National Instrument 51-102 Item 1 Names of the parties to the transaction MethylGene Inc.. (MethylGene) and Mirati Therapeutics, Inc. (Mirati) Item 2 Description of the transaction ...
FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company MethylGene Inc. (MethylGene) 7150 Frederick-Banting, Suite 200 Saint-Laurent, Qubec H4S 2A1 Item 2 Date of Material Change June 28, 2013. Item 3 News Release The news release attached hereto as Schedule ...
Date: June 26, 2013 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Microsoft Word - #6112944-v1-Report of Voting Results.DOC 6112944 v1 METHYLGENE INC. (the Corporation) REPORT OF VOTING RESULTS Section 11.3 of National Instrument 51-102 - Continuous Disclosure Obligations The following matters were voted upon at the annual and special meeting of shareholders of the Corporation held on June 25, 2013. Eac...
Date: June 25, 2013 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
_ Communiqu Symbole TSX : MYG LES ACTIONNAIRES DE METHYLGENE APPROUVENT LE PLAN DARRANGEMENT DE CONSTITUTION EN SOCIT AUX TATS-UNIS SOUS LE NOM DE MIRATI THERAPEUTICS, INC. Montral (Qubec) Canada, le 25 juin 2013 MethylGene Inc. ( MethylGene ) (TSX : MYG) annonce aujourdhui que, lors de lassemble annuelle et extraordinaire de...
News Release TSX Symbol: MYG METHYLGENE SHAREHOLDERS APPROVE THE PLAN OF ARRANGEMENT TO REINCORPORATE IN THE UNITED STATES AS MIRATI THERAPEUTICS INC. Montreal, Canada, June 25, 2013 MethylGene Inc. (MethylGene) (TSX:MYG) today announced that at its Annual and Special Meeting of Shareholders held in Montreal, Quebec (the Meeting...
Date: June 3, 2013 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
_ Communiqu Symbole TSX : MYG METHYLGENE PRSENTERA DES DONNES CLINIQUES SUR LE MOCTINOSTAT LORS DE LASSEMBLE ANNUELLE 2013 DE LAMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) Montral (Qubec) Canada, le 3 juin 2013 MethylGene Inc. (TSX : MYG) annonce aujourdhui que des donnes cliniques sur le moctinostat, linhibiteur dhistone-ds...
News Release TSX Symbol: MYG METHYLGENE PRESENTS CLINICAL DATA ON MOCETINOSTAT AT THE 2013 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING Montreal, Canada, June 3, 2013 MethylGene Inc. (TSX:MYG) today announced that clinical data for mocetinostat, the spectrum selective histone deacetylase (HDAC) inhibitor, was pres...
Date: May 30, 2013 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
_ Communiqu Symbole TSX : MYG PRSENTATION DE METHYLGENE LA CONFRENCE JEFFERIES 2013 DU SECTEUR DE LA SANT Montral (Qubec) Canada, le 30 mai 2013 MethylGene Inc. (TSX : MYG) annonce aujourdhui que le prsident et chef de la direction, Charles Baum, M.D., Ph.D., prsentera une vue densemble de la Socit lors de la confrence Jefferie...